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Abstract
Inhalable drugs are widely used for treating lung diseases such as asthma, emphysema, and cystic fibrosis. The aerosol
particles in these inhalable drugs may be charged electrostatically. The deposition of these inhaled therapeutic aerosol particles
in the different regions of the lung depends on the particle aerodynamic diameter, electrostatic charge distribution, particulate
number density, breathing rate, aerodynamics of the lung, ambient temperature, and relative humidity (RH). The primary
mechanisms for lung deposition of inhaled particles are impaction, gravitational settling, diffusion, interception, and
electrostatic attraction. To simulate lung deposition, electrostatically charged aerosol particles are introduced through a throat
section into a glass bead lung model. The E-SPART analyzer was used to measure aerosol deposition as a function of the
particle charge and size. Experiments were carried out to determine the increase in deposition efficiency as a function of the
net charge-to-mass ratio (Q/M) of aerosol particles. Using a fairly monodisperse aerosol of 5.0 um count median aerodynamic
diameter, it was found that the total deposition efficiency increased from 54% to 91% when Q/M increased from 0.5 to 9.67
|nC/g. The data show that enhanced delivery of the therapeutic aerosol in the lung can be achieved by controlling the
electrostatic charge on the inhaled aerosol particles.
Introduction
Inhalable drugs are widely used for treating lung
diseases such as asthma, emphysema and cystic fibrosis.
Localized delivery of drugs to the pulmonary tract has
become an increasingly important and effective therapeutic
method. Several studies show the clinical advantage of
inhalation aerosols over systemic therapy for the treatment
of lung disorders. Relatively small doses are required for
effective therapy, since delivering small doses of active
ingredients directly to the lung effectively targets the drug,
thereby maximizing therapeutic effect. Lower dosage
regimens may provide considerable cost savings, especially
with expensive therapeutic agents. The efficiency of a
therapeutic aerosol is mainly determined by the amount of
drug reaching the target site, which in turn depends on the
particle size, charge distribution, particulate number
density, and the breathing rate, aerodynamics of the lung,
and ambient temperature and relative humidity (RH). The
primary mechanisms for inhaled particle deposition are
impaction, gravitational settling, diffusion, interception and
electrostatic attraction. Electrostatic charge has been shown
to influence the deposition of inhaled particles within the
lung (Balachandran et al., 1991; Melandri et al., 1983). It was
found that with an increase in charge on the inhalable
particles, there was an increase in the fraction of drug
reaching the periphery of the pulmonary tract. Drug
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residence time and therefore duration of effect at the site of
action is a function of the rate of pulmonary clearance and
pulmonary absorption, which in turn are determined by
several factors, including the physicochemical properties of
the drug, such as molecular weight, dissolution rate,
partition coefficient, and charge. The therapeutic effect and
the duration of this effect are determined not only by the
drug dose and its pulmonary clearance, but also by particleto-particle interactions (Bailey et al., 1998; Balachandran et
al., 1997). These pulmonary drugs are inhaled from dry
powder inhalers, metered dose inhalers, spinning disk
aerosol generators, atomizers, or nebulizers. The overall
success of an aerosol delivery system is determined by its
components, the mechanism of dispersion, and patient
compliance. The challenges encountered with aerosol drug
delivery include the control of particle size, distribution, and
the reproducibility of dose uniformity.
The various sections of the experimental setup (Fig. 1)
to study the deposition were the spinning disk aerosol
generator, hollow cast larynx section, glass bead lung
model, sampling chamber, and the particle analyzer ESPART (Mazumder et al., 1991). A spinning disk aerosol
generator is used to produce aerosol particles in the range of
1-25 um. The ring electrode around the spinning disk of the
aerosol generator charges the particles, and by varying the
voltage the magnitude and polarity of charge of the particles
can be changed. Aerosolizing a liquid solution produces the
inhalable particles generated by the spinning disk aerosol
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Fig. 1. Shows the site-specific deposition system

to

study the effect of charge

generator. The liquid solution is injected as a continuous
stream at a constant flow rate onto a spinning disk. Due to

the high velocity of the spinning disk liquid droplets are
produced, which form an aerosol cloud. The droplets are
charged through induction charging. The airflow stream
carries this cloud.
The inhalable charged particles enter the hollow cast
throat section and the glass bead lung model (Fig. 2), where
they are deposited. A multi-layer granular bed filter was
designed to approximate the deposition characteristics of
the bronchial and alveolar regions of the human lung. The
sizes of the beads were selected to correspond to the sizes of
different bronchial orders as given in the Olson model of the
lung (Gao, 1994). The cross sectional area of the filter
increases as bead size decreases so that the calculated
Reynolds number through the beads is equal to that

on drug particles in surrogate lung models.

specified in the Olsen model for the corresponding
bronchial and trachobronchial orders. The airflow velocity
decreases by a factor of 250 in an actual human lung as air
reaches the lower regions of the lung. This is a result of the
increase in total cross-sectional area due to the large number
of airways. The particles in the different regions can be
analyzed for the aerodynamic diameter and charge-to-mass
ratio (Q/M) distributions using the E-SPART. From the
different regions of the glass bead lung model, the particles
enter the sampling chamber connected to the E-SPART
particle analyzer, which measures the size and charge
distributions of particles in the aerodynamic diameter range
of 1-25 urn.
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Fig. 2. Shows hollow cast larynx section and glass bead lung model.

Materials and Methods

Results and Discussion

To generate the test aerosol, a solution of 2% emery oil
and 98% alcohol was prepared. Changing the percentage of
emery oilin the alcohol solution controlled the particle size.
The liquid solution was fed to the spinning disk aerosol
generator to produce inhalable aerosol particles of specific
size. By applying voltage on the ring electrode, the particles
acquired charge. When +30 volts were applied on the ring
electrode, particles with an average Q/M of -4.21 uC/g
were obtained. When -30 volts are applied, particles with a
Q/M of + 9.67 uC/g were obtained. Test aerosols with wellcharacterized size and charge distributions entered the
hollow cast larynx section where the large particles
deposited (Wesley et al., 2000; Schlesinger et al., 1977). The
particles then entered the glass bead lung model. The
particles, depending on their size and charge, deposited in
the various sections of the model. The particles from the
different sections of the glass bead lung model were sampled
to determine the particle size and charge distribution. The
E-SPART sampled the particles from the sampling chamber
at a rate of 3 lpm.

Figures 3-8 show the particle size distributions (PSDs) of
the aerosol particles from the glass bead lung model.
Lognormal distribution was selected empirically to fit the
wide range and skewed shape of aerosol size distributions.
Keeping all variables such as airflow and liquid solution flow
rate constant, the aerosol cloud was fed from the aerosol
generator through the three layers of the glass bead model
and its PSD was measured. When the particle number
density was high, there was mutual repulsion between the
particles, and they deposited on the glass beads and the wall.
However, ifthe particle number density was low, the image
force acting on the particle due to the presence of glass
beads and the wall was the principal force responsible for
particle deposition.
Figure 3 shows the PSD of particles coming from the
spinning disk aerosol generator as measured by the ESPART. The number of particles was found to decrease
from 18136 to 8184 (Fig. 4) when measured for 5 min at the
inlet and outlet. Thus the efficiency of deposition was found
to be only 54%, and the remaining 46% of the particles
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Fig. 3. PSD of uncharged particles from the spinning disk aerosol generator. The aerosol particles have a CMAD = 4.8 um and
MMAD= 5.5 um, which was measured by the particle analyzer ESPART.

passed through the glass bead lung model. The aerosolized
particles from the spinning disk aerosol generator were
fairly monodisperse. Figures 5 and 6 show the PSD of
positively charged particles from the spinning disk aerosol
generator and from the model. The PSD after the particles
passed through the lung model was wider. The number of
particles was found to decrease from 14998 to 1294,
increasing the deposition efficiency to 91%. Similarly, it was
found that for negatively charged particles the particle count
fell from 15727 to 1036, resulting in an efficiency of 93%.

Conclusions
The particle deposition was found to be dependent on
the distribution of particle charge and size. Due to the image
forces or the mutual repulsion of the particles, the
deposition is found to increase. By controlling the charge
and particle size distributions of the drug particles, itmay be
possible to control their deposition in the various regions of
the lung.
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Fig. 4. PSD of uncharged particles collected after the aerosol passed through the first three sections of the lung model. Particle
CMAD = 4.5 urn and MMAD= 6.9 urn.

Fig. 5. PSD of positively charged particles collected from the spinning disk aerosol generator. Particle CMAD = 4.8 um and
MMAD= 4.9 um.
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Fig. 6. PSD of positively charged particles collected after the aerosol passed through the first three sections of the lung model
Particle CMAD = 3.9 urn and MMAD= 4.6 um.

Fig. 7. PSD of negatively charged particles collected from the spinning disk aerosol generator. Particle CMAD = 4.9 um and
MMAD= 5.1 um.
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Fig. 8. PSD of negatively charged particles collected after the aerosol passed through the first three sections of the lung model.
Particle CMAD= 4.7 urn and MMAD = 5.1 urn.
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